Antigen presentation by MHC class II molecules: Invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture

Human Immunology

Volumn 54, Issue 2, 1997, Pages 159-169

  Castellino, Flora ^a   Zhong, Guangming ^a   Germain, Ronald N ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ENDOCYTOSIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN TRANSPORT; REVIEW; T LYMPHOCYTE;

ANTIGEN PRESENTATION; ANTIGENS; BIOLOGICAL TRANSPORT; CD4-POSITIVE T-LYMPHOCYTES; GOLGI APPARATUS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDES; PROTEINS;

EID: 0030806054     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00078-5     Document Type: Review

References (88)

1. Germain RN: MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287, 1994.
2. Kaufman JF, Auffray C, Korman AJ, Shackelford DA, Strominger J: The class II molecules of the human and murine major histocompatibility complex. Cell 36:1, 1984.
3. Germain RN, Margulies DH: The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 11:403, 1993.
4. b. Science 257: 919, 1992.
5. Madden DR, Gorga JC, Strominger JL, Wiley DC: The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70:1035, 1992.
6. Matsumura M, Fremont DH, Peterson PA, Wilson IA: Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257:927, 1992.
7. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33, 1993.
8. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC: Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215, 1994.
9. Stern LJ, Wiley DC: Antigenic peptide binding by class I and class II histocompatibility proteins. Structure 2:245, 1994.
10. Rudensky A, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA Jr: Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622, 1991.
11. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DA, Strominger JL: Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764, 1992.
12. d. Science 256:1817, 1992.
13. Rudensky A, Preston-Hurlburt P, al-Ramadi BK, Rothbard J, Janeway CA Jr: Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature 359:429, 1992.
14. Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL: Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 178:27, 1993.
15. Chicz RM, Lane WS, Robinson RA, Trucco M, Strominger JL, Gorga JC: Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. Int Immunol 6:1639, 1994.
16. Momburg F, Roelse J, Hämmerling GJ, Neefjes JJ: Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J Exp Med 179:1613, 1994.
17. Androlewicz MJ, Cresswell P: Human transporters associated with antigen processing possess a promiscuous peptide-binding site. Immunity 1:7, 1994.
18. Cresswell P: Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 12:259, 1994.
19. Roche PA, Marks MS, Cresswell P: Formation of a ninesubunit complex by HLA class II glycoproteins and the invariant chain. Nature 354:392, 1991.
20. Claesson-Welsh L, Peterson PA: Implications of the invariant gamma-chain on the intracellular transport of class II histocompatibility antigens. J Immunol 135:3551, 1985.
21. Lotteau V, Teyton L, Peleraux A, Nilsson T, Karlsson L, Schmid SL, Quaranta V, Peterson PA: Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348:600, 1990.
22. Roche PA, Cresswell P: Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345:615, 1990.
23. Teyton L, O'Sullivan D, Dickson PW, Lotteau V, Sette A, Fink P, Peterson PA: Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 348:39, 1990.
24. Layet C, Germain RN: Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex AαAβ dimers from the endoplasmic reticulum/cis-Golgi compartment. Proc Natl Acad Sci USA 88:2346, 1991.
25. Anderson MS, Miller J: Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc Natl Acad Sci USA 89:2282, 1992.
26. Viville S, Neefjes J, Lotteau V, Dierich A, Lemeur M, Ploegh H, Benoist C, Mathis D: Mice lacking the MHC class II-associated invariant chain. Cell 72:635, 1993.
27. Bikoff EK, Huang LY, Episkopou V, van Meerwijk J, Germain RN, Robertson EJ: Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression. J Exp Med 177:1699, 1993.
28. Elliott EA, Drake JR, Amigorena S, Elsemore J, Webster P, Mellman I, Flavell RA: The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J Exp Med 179:681, 1994.
29. Bikoff EK, Germain RN, Robertson EJ: Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 2:301, 1995.
30. Bonnerot C, Marks MS, Cosson P, Robertson EJ, Bikoff EK, Germain RN, Bonifacino JS: Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain. EMBO J 13:934, 1994.
31. Marks MS, Germain RN, Bonifacino JS: Transient aggregation of major histocompatibility complex class II chains during assembly in normal spleen cells. J Biol Chem 270:10475, 1995.
32. Freisewinkel IM, Schenck K, Koch N: The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc Natl Acad Sci USA 90:9703, 1993.
33. Bijlmakers MJ, Benaroch P, Ploegh HL: Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J Exp Med 180:623, 1994.
34. Romagnoli P, Germain RN: The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J Exp Med 180:1107, 1994.
35. Avva RR, Cresswell P: In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1:763, 1994.
36. Ghosh P, Amaya M, Mellins E, Wiley DC: The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457, 1995.
37. Germain RN, Hendrix LR: MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134, 1991.
38. Sadegh-Nasseri S, Germain RN: A role for peptide in determining MHC class II structure. Nature 353:167, 1991.
39. Busch R, Vturina IY, Drexler J, Momburg F, Hammerling GJ: Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain. Eur J Immunol 25:48, 1995.
40. Busch R, Cloutier I, Sekaly RP, Hämmerling GJ: Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J 15:418, 1996.
41. Germain RN: Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function. Semin Immunol 7:361, 1995.
42. Kozono H, White J, Clements J, Marrack P, Kappler J: Production of soluble MHC class II proteins with covalently bound single peptides. Nature 369:151, 1994.
43. Zhong G, Castellino F, Romagnoli P, Germain RN: Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP). J Exp Med 184:2061, 1996.
44. Snider DP, Segal DM: Targeted antigen presentation using crosslinked antibody heteroaggregates. J Immunol 139:1609, 1987.
45. Casten LA, Kaumaya P, Pierce SK: Enhanced T cell responses to antigenic peptides targeted to B cell surface Ig, Ia, or class I molecules. J Exp Med 168:171, 1988.
46. Niebling WL, Pierce SK: Antigen entry into early endosomes is insufficient for MHC class II processing. J Immunol 150:2687, 1993.
47. Harding CV, Collins D, Unanue ER: Processing of liposome-encapsulated antigens targeted to specific subcellular compartments. Res Immunol 143:188, 1992.
48. Loss G Jr, Sant AJ: Invariant chain retains MHC class II molecules in the endocytic pathway. J Immunol 150: 3187, 1993.
49. Neefjes JJ, Ploegh HL: Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance αβ heterodimers in endosomes. EMBO J 11: 411, 1992.
50. Bremnes B, Madsen T, Gedde-Dahl M, Bakke O: An LI and ML motif in the cytoplasmic tail of the MHC-associated invariant chain mediate rapid internalization. J Cell Sci 107:2021, 1994.
51. Nowell J, Quaranta V: Chloroquine affects biosynthesis of Ia molecules by inhibiting dissociation of invariant (gamma) chains from α-β dimers in B cells. J Exp Med 162:1371, 1985.
52. Blum JS, Cresswell P: Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc Natl Acad Sci USA 85:3975, 1988.
53. Peters PJ, Neefjes JJ, Oorschot V, Ploegh HL, Geuze HJ: Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349:669, 1991.
54. Harding CV, Geuze HJ: Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells. J Cell Biol 119: 531, 1992.
55. Harding CV, Geuze HJ: Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment. J Immunol 151:3988, 1993.
56. Romagnoli P, Layet C, Yewdell J, Bakke O, Germain RN: Relationship between invariant chain expression and MHC class II transport into early and late endocytic compartments. J Exp Med 177:583, 1993.
57. Roche PA, Teletski CL, Stang E, Bakke O, Long EO: Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc Natl Acad Sci USA 90:8581, 1993.
58. Castellino F, Germain RN: Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity 2:73, 1995.
59. Benaroch P, Yilla M, Raposo G, Ito K, Miwa K, Geuze HJ, Ploegh HL: How MHC class II molecules reach the endocytic pathway. EMBO J 14:37, 1995.
60. Amigorena S, Drake JR, Webster P, Mellman I: Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369: 113, 1994.
61. Tulp A, Verwoerd D, Dobberstein B, Ploegh HL, Pieters J: Isolation and characterization of the intracellular MHC class II compartment. Nature 369:120, 1994.
62. West MA, Lucocq JM, Watts C: Antigen processing and class II MHC peptide-loading in human B-lymphoblastoid cells. Nature 369:147, 1994.
63. Fling SP, Arp B, Pious D: HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368:554, 1994.
64. Morris P, Shaman J, Attaya M, Amaya M, Goodman S, Bergman C, Monaco JJ, Mellins E: An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368:551, 1994.
65. Pierre P, Denzin LK, Hammond C, Drake JR, Amigorena S, Cresswell P, Mellman I: HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments. Immunity 4:229, 1996.
66. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K: Dominance and crypticity of T cell antigenie determinants. Annu Rev Immunol 11:729, 1993.
67. Germain RN, Rinker AG Jr: Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature 363:725, 1993.
68. Sette A, Southwood S, Miller J, Appella E: Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J Exp Med 181:677, 1995.
69. Mellman I: Endocytosis and antigen processing. Semin Immunol 2:229, 1990.
70. Schwartz RH: T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu Rev Immunol 3:237, 1985.
71. Rothbard JB, Gefter ML: Interactions between immunogenic peptides and MHC proteins. Annu Rev Immunol 9:527, 1991.
72. Denzin LK, Hammond C, Cresswell P: HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J Exp Med 184:2153, 1996.
73. Deng H, Apple R, Clare-Salzler M, Trembleau S, Mathis D, Adorini L, Sercarz E: Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J Exp Med 178:1675, 1993.
74. Falk K, Rötzschke O, Stevanovic S, Jung G, Rammensee HG: Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 39:230, 1994.
75. Werdelin O: Determinant protection. A hypothesis for the activity of immune response genes in the processing and presentation of antigens by macrophages. Scand J Immunol 24:625, 1986.
76. Donermeyer DL, Allen PM: Binding to Ia protects an immunogenic peptide from proteolytic degradation. J Immunol 142:1063, 1989.
77. Mouritsen S, Meldal M, Werdelin O, Hansen AS, Buus S: MHC molecules protect T cell epitopes against proteolytic destruction. J Immunol 149:1987, 1992.
78. Nadimi F, Moreno J, Momburg F, Heuser A, Fuchs S, Adorini L, Hämmerling GJ: Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain. Eur J Immunol 21:1255, 1991.
79. Momburg F, Fuchs S, Drexler J, Busch R, Post M, Hämmerling GJ, Adorini L: Epitope-specific enhancement of antigen presentation by invariant chain. J Exp Med 178: 1453, 1993.
80. Pinet V, Vergelli M, Martin R, Bakke O, Long EO: Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375:603, 1995.
81. Williams MA, Fukuda M: Accumulation of membrane glycoproteins in lysosomes requires a tyrosine residue at a particular position in the cytoplasmic tail. J Cell Biol 111:955, 1990.
82. Collawn JF, Stangel M, Kuhn LA, Esekogwu V, Jing SQ, Trowbridge IS, Tainer JA: Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis. Cell 63:1061, 1990.
83. Letourneur F, Klausner RD: A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell 69:1143, 1992.
84. Johnson KF, Kornfeld S: The cytoplasmic tail of the mannose 6-phosphate/insulin-like growth factor-II receptor has two signals for lysosomal enzyme sorting in the Golgi. J Cell Biol 119:249, 1992.
85. Collawn JF, Lai A, Domingo D, Fitch M, Hatton S, Trowbridge IS: YTRF is the conserved internalization signal of the transferrin receptor, and a second YTRF signal at position 31-34 enhances endocytosis. J Biol Chem 268:21686, 1993.
86. Verhey KJ, Birnbaum MJ: A Leu-Leu sequence is essential for COOH-terminal targeting signal of GLUT4 glucose transporter in fibroblasts. J Biol Chem 269:2353, 1994.
87. Zhong G, Romagnoli P, Germain RN: Related leucinebased cytoplasmic targeting signals in invariant chain and MHC class II molecules control endocytic presentation of distinct determinants in a single protein. J Exp Med 185:429, 1997.
88. Verhey KJ, Yeh JI, Birnbaum MJ: Distinct signals in the GLUT4 glucose transporter for internalization and for targeting to an insulin-responsive compartment. J Cell Biol 130:1071, 1995.